跳至主要内容
临床试验/IRCT20210423051047N2
IRCT20210423051047N2已完成2 期

Anti-inflammatory effect of cholchicine in acute coronary syndrome

Iran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 no limit(—)
性别
All

入选标准

  • A patient over 20 years of age with ST Elevated MI who is a candidate for Primary PCI and presented within less than 12 hours of the onset of pain

排除标准

  • Cardiogenic shock or hemodynamic instability
  • Known hypersensitivity to colchicine
  • Patients with a history of chronic kidney and liver disease
  • Thrombocytopenia or leukopenia
  • Pregnant or lactating women
  • Patients receiving CYP3A4 inhibitors
  • Patients already taking colchicine
  • Patients who have evidence of active or inflammatory infection
  • Patients with a history of AF or MI
  • Patients with a history of CABG
  • MI patients in the field of stent thrombosis

研究者

相似试验